Chemed schedules results as five of six analysts rate Chemed stock Hold
Published on 10/06/2026 at 12:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Chemed (ISIN US16359R1032) was trading at EUR 457.00 at Lang & Schwarz on October 6, 2026, up 0.44 percent from the prior close of EUR 455.00. GlobeNewswire reported on October 1, 2026 that Chemed will release third-quarter results on October 27, 2026, after the close of trading. MarketBeat said on September 18, 2026 that five of six brokerages rated the stock Hold and one rated it Buy.
Second-quarter results raised the bar
Chemed reported second-quarter 2026 revenue of USD 673.25 million, up 8.80 percent from the same quarter a year earlier, according to MarketBeat. Adjusted earnings per share reached USD 6.06, compared with the USD 5.60 consensus estimate, a USD 0.46 difference.
The same report put the prior-year quarterly earnings-per-share figure at USD 4.27, making the latest adjusted result USD 1.79 higher. Chemed also set fiscal 2026 earnings-per-share guidance at USD 25.00-25.75, while analysts expected USD 23.55 for the year.
October 27 brings the next test
The scheduled release covers the quarter ended September 30, 2026, and a conference call is set for October 28, 2026, according to GlobeNewswire. That timing puts the next operating update ahead of the fiscal 2026 earnings-per-share guidance range and the USD 530.75 average analyst target reported by MarketBeat.
Chemed operates through VITAS Healthcare and Roto-Rooter, combining hospice care with plumbing and drain-cleaning services. The two businesses give the upcoming report two distinct operating areas to evaluate.
EUR 457.00 in afternoon trading
Chemed was trading at EUR 457.00 at Lang & Schwarz on October 6, 2026 at 12:10 p.m. CEST, plus 0.44 percent versus the prior close of EUR 455.00. On the NYSE, the stock was last at USD 511.30 on October 5, 2026 at 4:00 p.m. EDT, within its USD 365.21 to USD 557.00 52-week range.
Chemed market snapshot
- Company: Chemed Corporation
- ISIN: US16359R1032
- Ticker: CHE
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 6, 2026, 12:10 p.m. CEST): EUR 457.00
- Change versus prior close: plus 0.44 percent
- Prior close Lang & Schwarz (October 5, 2026): EUR 455.00
- Market capitalization: USD 6.7 billion (as of October 5, 2026)
- 52-week range: USD 365.21-USD 557.00 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Index membership: S&P 600 SmallCap
- Next earnings date: October 27, 2026
